Joseph Keegan, Richard Zakour, Joel Schaefer | GenomeWeb
Seahorse Bioscience, a developer of cellular analysis tools, has appointed Joseph Keegan to its board of directors. Keegan was previously CEO of Molecular Devices. Prior to that, he was president of worldwide tissue culture at Becton Dickinson and vice president of Leica’s microscopy and scientific instruments division.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.